A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.

Date publication

août 2023

Journal

European urology open science

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier

Tous les auteurs :
Pasquier D, Nickers P, Peiffert D, Maingon P, Pommier P, Lacornerie T, Tresch E, Barthoulot M, Lartigau E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37545850

Résumé

Genitourinary (GU) or gastrointestinal (GI) complications and tumor relapse can occur in the long term after radiotherapy for prostate cancer.

Mots clés

Intermediate-risk prostate cancer, Prostate cancer, Stereotactic body radiotherapy, Stereotactic body radiotherapy boost

Référence

Eur Urol Open Sci. 2023 08;54:80-87